Dicerna Pharmaceuticals Joins Biotech IPO Queue, Plans $69 Million Raise
When Dicerna Pharmaceuticals hauled in $60 million back in August, CEO Doug Fambrough hinted that an IPO was on the way. The Watertown, MA-based company made good on that prediction this morning. Dicerna has filed papers with the Securities and Exchange Commission outlining plans to raise up to $69 million from public investors through an IPO.
Help employers find you! Check out all the jobs and post your resume.